Cargando…

Enzyme Activity in Relation to Cancer: Inhibition of Urinary β-Glucuronidase of Patients with Cancer of the Bladder by Oral Administration of 1:4-Saccharolactone and Related Compounds

Detalles Bibliográficos
Autores principales: Boyland, E., Wallace, D. M., Williams, D. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1957
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2073720/
https://www.ncbi.nlm.nih.gov/pubmed/13510516
_version_ 1782137822067556352
author Boyland, E.
Wallace, D. M.
Williams, D. C.
author_facet Boyland, E.
Wallace, D. M.
Williams, D. C.
author_sort Boyland, E.
collection PubMed
description
format Text
id pubmed-2073720
institution National Center for Biotechnology Information
language English
publishDate 1957
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20737202009-09-10 Enzyme Activity in Relation to Cancer: Inhibition of Urinary β-Glucuronidase of Patients with Cancer of the Bladder by Oral Administration of 1:4-Saccharolactone and Related Compounds Boyland, E. Wallace, D. M. Williams, D. C. Br J Cancer Articles Nature Publishing Group 1957-12 /pmc/articles/PMC2073720/ /pubmed/13510516 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Articles
Boyland, E.
Wallace, D. M.
Williams, D. C.
Enzyme Activity in Relation to Cancer: Inhibition of Urinary β-Glucuronidase of Patients with Cancer of the Bladder by Oral Administration of 1:4-Saccharolactone and Related Compounds
title Enzyme Activity in Relation to Cancer: Inhibition of Urinary β-Glucuronidase of Patients with Cancer of the Bladder by Oral Administration of 1:4-Saccharolactone and Related Compounds
title_full Enzyme Activity in Relation to Cancer: Inhibition of Urinary β-Glucuronidase of Patients with Cancer of the Bladder by Oral Administration of 1:4-Saccharolactone and Related Compounds
title_fullStr Enzyme Activity in Relation to Cancer: Inhibition of Urinary β-Glucuronidase of Patients with Cancer of the Bladder by Oral Administration of 1:4-Saccharolactone and Related Compounds
title_full_unstemmed Enzyme Activity in Relation to Cancer: Inhibition of Urinary β-Glucuronidase of Patients with Cancer of the Bladder by Oral Administration of 1:4-Saccharolactone and Related Compounds
title_short Enzyme Activity in Relation to Cancer: Inhibition of Urinary β-Glucuronidase of Patients with Cancer of the Bladder by Oral Administration of 1:4-Saccharolactone and Related Compounds
title_sort enzyme activity in relation to cancer: inhibition of urinary β-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2073720/
https://www.ncbi.nlm.nih.gov/pubmed/13510516
work_keys_str_mv AT boylande enzymeactivityinrelationtocancerinhibitionofurinarybglucuronidaseofpatientswithcancerofthebladderbyoraladministrationof14saccharolactoneandrelatedcompounds
AT wallacedm enzymeactivityinrelationtocancerinhibitionofurinarybglucuronidaseofpatientswithcancerofthebladderbyoraladministrationof14saccharolactoneandrelatedcompounds
AT williamsdc enzymeactivityinrelationtocancerinhibitionofurinarybglucuronidaseofpatientswithcancerofthebladderbyoraladministrationof14saccharolactoneandrelatedcompounds